Neogen Stock Current Asset
| NEOG Stock | USD 14.14 0.03 0.21% |
Neogen fundamentals help investors to digest information that contributes to Neogen's financial success or failures. It also enables traders to predict the movement of Neogen Stock. The fundamental analysis module provides a way to measure Neogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neogen stock.
The Neogen's current Non Current Assets Total is estimated to increase to about 4.2 B. The Neogen's current Other Current Assets is estimated to increase to about 58.8 M. Neogen | Current Asset |
Neogen Company Current Asset Analysis
Neogen's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Neogen Current Asset | 250 M |
Most of Neogen's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neogen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Neogen Current Asset Historical Pattern
Today, most investors in Neogen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Neogen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Neogen current asset as a starting point in their analysis.
Neogen Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Neogen Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Neogen has a Current Asset of 250 M. This is 88.38% lower than that of the Health Care Equipment & Supplies sector and 74.61% lower than that of the Health Care industry. The current asset for all United States stocks is 97.32% higher than that of the company.
Neogen Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neogen's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics of similar companies.Neogen is currently under evaluation in current asset category among its peers.
Neogen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Neogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Neogen's managers, analysts, and investors.Environmental | Governance | Social |
Neogen Fundamentals
| Return On Equity | -0.0075 | ||||
| Return On Asset | 0.0085 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 3.84 B | ||||
| Shares Outstanding | 216.7 M | ||||
| Shares Owned By Insiders | 0.26 % | ||||
| Shares Owned By Institutions | 99.74 % | ||||
| Number Of Shares Shorted | 19.68 M | ||||
| Price To Earning | 13.36 X | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 3.37 X | ||||
| Revenue | 924.22 M | ||||
| Gross Profit | 409.2 M | ||||
| EBITDA | 182.6 M | ||||
| Net Income | (9.42 M) | ||||
| Cash And Equivalents | 347.71 M | ||||
| Cash Per Share | 3.22 X | ||||
| Total Debt | 906.24 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 9.07 X | ||||
| Book Value Per Share | 14.47 X | ||||
| Cash Flow From Operations | 35.26 M | ||||
| Short Ratio | 15.91 X | ||||
| Earnings Per Share | (0.11) X | ||||
| Price To Earnings To Growth | 0.66 X | ||||
| Target Price | 16.5 | ||||
| Number Of Employees | 2.92 K | ||||
| Beta | 1.22 | ||||
| Market Capitalization | 3.07 B | ||||
| Total Asset | 4.55 B | ||||
| Retained Earnings | 555.62 M | ||||
| Working Capital | 434.91 M | ||||
| Current Asset | 250 M | ||||
| Current Liabilities | 28.6 M | ||||
| Net Asset | 4.55 B |
About Neogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:Check out Neogen Piotroski F Score and Neogen Altman Z Score analysis. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (0.11) | Revenue Per Share 4.212 | Quarterly Revenue Growth (0.05) | Return On Assets 0.0085 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.